OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics
Vadim Fedyuk, Nir Erez, Noa Furth, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 2, pp. 212-221
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 76

Exploring sin-Gaussian laser pulses for efficient electron acceleration in plasma
Vivek Sharma, Niti Kant, Vishal Thakur
Optical and Quantum Electronics (2024) Vol. 56, Iss. 4
Closed Access | Times Cited: 14

Laser Wakefield Effect: A Comparative Study of Gaussian and Sinh-Gaussian Pulse Characteristics
Vivek Sharma, Niti Kant, Vishal Thakur
Brazilian Journal of Physics (2024) Vol. 54, Iss. 3
Closed Access | Times Cited: 6

Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
WY Tsui, Spencer C. Ding, Peiyong Jiang, et al.
Genome Research (2025) Vol. 35, Iss. 1, pp. 1-19
Closed Access

Circulating Histones to Detect and Monitor the Progression of Cancer
Desislava K. Tsoneva, Martin Ivanov, Nikolay Conev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 942-942
Open Access | Times Cited: 18

Circulating nucleosomes as potential biomarkers for cancer diagnosis and treatment monitoring
Huawei Wang, Yin Wang, Dejiu Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 130005-130005
Closed Access | Times Cited: 5

High-throughput single biomarker identification using droplet nanopore
Lin-Lin Zhang, Cheng-Bing Zhong, Ting-Jing Huang, et al.
Chemical Science (2024) Vol. 15, Iss. 22, pp. 8355-8362
Open Access | Times Cited: 4

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 4

Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
Changshu Li, Jun Shao, Peiyi Li, et al.
Cancer Letters (2023) Vol. 577, pp. 216365-216365
Open Access | Times Cited: 11

Review of Molecular Technologies for Investigating Canine Cancer
Alexandra Kehl, Heike Aupperle‐Lellbach, Simone de Brot, et al.
Animals (2024) Vol. 14, Iss. 5, pp. 769-769
Open Access | Times Cited: 3

Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
Jodie Wong, Rohit Muralidhar, Liang Wang, et al.
Biomedical Journal (2024), pp. 100718-100718
Open Access | Times Cited: 3

Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation
Ilana Fox-Fisher, Ruth Shemer, Yuval Dor
Trends in Immunology (2023) Vol. 44, Iss. 5, pp. 356-364
Closed Access | Times Cited: 9

Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
Xin Liu, Yue Yang, Ren Zihan, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 8

Liquid biopsies for cancer: From bench to clinic
Zhenhui Chen, Chenghao Li, Yue Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 8

The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

Targeting therapy-persistent residual disease
Xiaoxiao Sun, Lani F. Wu, Steven J. Altschuler, et al.
Nature Cancer (2024)
Closed Access | Times Cited: 2

Current and emerging applications of liquid biopsy in pan-cancer
Wenxiang Wang, Yue He, Fan Yang, et al.
Translational Oncology (2023) Vol. 34, pp. 101720-101720
Open Access | Times Cited: 7

Liquid Biopsy in H3K27M Diffuse Midline Glioma
J.D. Patel, Rayan Aittaleb, Robert Doherty, et al.
Neuro-Oncology (2023) Vol. 26, Iss. Supplement_2, pp. S101-S109
Open Access | Times Cited: 7

Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery
Lucas Penny, Sasha Main, Steven De Michino, et al.
Biochemistry and Cell Biology (2024) Vol. 102, Iss. 4, pp. 291-298
Open Access | Times Cited: 1

HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis
Lihong Yang, Yong Ruan, Houqiang Xu
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

It’s all in the combination: decoding the epigenome for cancer research and diagnostics
Noa Furth, Efrat Shema
Current Opinion in Genetics & Development (2022) Vol. 73, pp. 101899-101899
Open Access | Times Cited: 9

Liquid Liver Biopsy for Disease Diagnosis and Prognosis
Desislava K. Tsoneva, Martin Ivanov, Manlio Vinciguerra
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1520-1541
Open Access | Times Cited: 4

Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosis
Yuqing Sun, Yongling Tang, Long Yu, et al.
Science China Chemistry (2023) Vol. 66, Iss. 11, pp. 3006-3023
Closed Access | Times Cited: 4

Optical Imaging of a Single Molecule with Subnanometer Resolution by Photoinduced Force Microscopy
Tatsuya Yamamoto, Hidemasa Yamane, Nobuhiko Yokoshi, et al.
ACS Nano (2023)
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top